Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website http://australasianmelanoma.org/

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Cancer in the News

Feature Articles

Study Shows Efficacy of Neoadjuvant Combo Therapy in Melanoma, Cautions Toxicity

Source: Specialty Pharmacy Times, November 2018 A neoadjuvant therapeutic approach demonstrated a clinical benefit for patients with high-risk melanoma, but toxicity concerns suggest the need for further optimization to reduce adverse effects, according to a new study. In the phase 2 study, which was published in Nature Medicine, researchers at The University of Texas MD Anderson […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Evaluating the Role of the Gut Microbiome to Bolster Immunotherapy Response in Melanoma

Source: Targeted Oncology, November 2018 A new area of research in the treatment landscape of melanoma focuses on manipulating the gut microbiome to improve immunotherapy responses, particularly with anti–PD-1 and anti–CTLA-4 antibodies. Based on data seen in several mouse studies in Chicago and France, it is suggested that altering the microbiome may be necessary to […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Immune-Related Adverse Events Due to Checkpoint Inhibition Are More Common in Melanoma Than in NSCLC

Source: Cancer Therapy Advisor, November 2018 More patients with melanoma who were treated with either nivolumab or pembrolizumab developed immune-related adverse events (irAEs) compared with patients with non-small cell lung cancer (NSCLC) treated with these same checkpoint inhibitors, suggesting differences in these events across groups. However, more studies will be needed to determine whether the association between […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

Combining genetic and sun exposure data improves skin cancer risk estimates

Source: Ecancer News, November 2018 By combining data on individuals’ lifetime sun exposure and their genetics, researchers can generate improved predictions of their risk of skin cancer, according to findings presented at the American Society of Human Genetics (ASHG) 2018 Annual Meeting in San Diego, Calif. Pierre Fontanillas, PhD, and colleagues at 23andMe, Inc., collected genetic and […]

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest